Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 6Other hematologic neoplasm 2Myeloid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 27Philadelphia Chromosome 3Leukemia, Myeloid, Chronic-Phase 3Leukemia 3Blast Crisis 3Bronchiolitis Obliterans Syndrome 2Translocation, Genetic 1Pathologic Processes 1Neoplasms by Histologic Type 1Myeloproliferative Disorders 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Hematologic Diseases 1Breast Neoplasms 1Bone Marrow Diseases 1

Interventions

Therapeutics 6Flow Cytometry 5Psychiatric Rehabilitation 3Immunologic Techniques 3Cyclophosphamide 3Amplified Fragment Length Polymorphism Analysis 3ruxolitinib 2pembrolizumab 2liposomal amphotericin B 2abiraterone 2Vorinostat 2Sirolimus 2Radiotherapy 2Polymerase Chain Reaction 2Ondansetron 2Mycophenolic Acid 2Methylprednisolone 2Itraconazole 2Ipilimumab 2Immunoglobulin G 2Immunoenzyme Techniques 2Gemcitabine 2Doxorubicin 2Disulfides 2Dexamethasone 2Deferasirox 2Caspofungin 2Calcium Dobesilate 2CTLA-4 Antigen 2Bevacizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × bosutinib × Myeloid × Clear all
NCT00759837 2009-07-16

Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects

Wyeth is now a wholly owned subsidiary of Pfizer

Phase 1 Completed
27 enrolled
BreastMyeloidOther hematologic neoplasm

Breast Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡